Despite being marginally statistically significant, weight gain of 0.4 kg after 6 months of treatment with insulin Gla-300 was clinically not relevant, especially taken into account the marked improvement of glycemic control.
← all excerpts
Effectiveness and safety of insulin glargine Gla-300 in insulin-naïve type 2 diabetes subjects in a real-life setting-the GOAL_RO trial.
1
—
—